3,942 Shares in Dolby Laboratories, Inc. (NYSE:DLB) Purchased by Vise Technologies Inc.

Vise Technologies Inc. purchased a new position in shares of Dolby Laboratories, Inc. (NYSE:DLBFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,942 shares of the electronics maker’s stock, valued at approximately $308,000.

Other large investors have also recently made changes to their positions in the company. Savant Capital LLC grew its stake in Dolby Laboratories by 2.0% in the 4th quarter. Savant Capital LLC now owns 6,274 shares of the electronics maker’s stock worth $490,000 after acquiring an additional 125 shares in the last quarter. Orion Portfolio Solutions LLC grew its stake in Dolby Laboratories by 0.7% in the 4th quarter. Orion Portfolio Solutions LLC now owns 19,522 shares of the electronics maker’s stock worth $1,525,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. grew its stake in Dolby Laboratories by 36.8% in the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker’s stock worth $41,000 after acquiring an additional 142 shares in the last quarter. Naples Global Advisors LLC grew its stake in Dolby Laboratories by 0.4% in the 4th quarter. Naples Global Advisors LLC now owns 35,730 shares of the electronics maker’s stock worth $2,791,000 after acquiring an additional 160 shares in the last quarter. Finally, Fifth Third Bancorp grew its stake in Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock worth $28,000 after acquiring an additional 163 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Stock Performance

Shares of DLB opened at $75.46 on Wednesday. The company has a 50 day moving average price of $75.73 and a 200-day moving average price of $78.58. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.66. The stock has a market capitalization of $7.25 billion, a PE ratio of 27.74 and a beta of 0.95.

Dolby Laboratories (NYSE:DLBGet Free Report) last announced its quarterly earnings results on Thursday, May 1st. The electronics maker reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.05. The firm had revenue of $369.56 million during the quarter, compared to analysts’ expectations of $375.44 million. Dolby Laboratories had a net margin of 19.97% and a return on equity of 11.32%. The company’s revenue was up 1.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.27 EPS. Equities research analysts forecast that Dolby Laboratories, Inc. will post 2.94 EPS for the current year.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 21st. Investors of record on Tuesday, May 13th were paid a dividend of $0.33 per share. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $1.32 annualized dividend and a dividend yield of 1.75%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 49.81%.

Analyst Ratings Changes

DLB has been the topic of a number of research analyst reports. Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, May 2nd. Rosenblatt Securities dropped their target price on shares of Dolby Laboratories from $100.00 to $95.00 and set a “buy” rating on the stock in a research note on Friday, May 2nd. Tigress Financial started coverage on shares of Dolby Laboratories in a research note on Thursday, May 15th. They issued a “buy” rating and a $112.00 target price on the stock. Finally, Wall Street Zen lowered shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a report on Friday, January 31st.

View Our Latest Stock Analysis on DLB

Insider Buying and Selling

In related news, SVP John D. Couling sold 675 shares of the business’s stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $75.04, for a total transaction of $50,652.00. Following the completion of the transaction, the senior vice president now owns 121,151 shares in the company, valued at $9,091,171.04. The trade was a 0.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 38.39% of the stock is currently owned by company insiders.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Articles

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.